Abstract
Coronavirus disease 2019 (COVID-19) vaccines are being developed and implemented with unprecedented speed. Accordingly, trials considered ethical at their inception may quickly become concerning. We provide recommendations for Data and Safety Monitoring Boards (DSMBs) on monitoring the ethical acceptability of COVID-19 vaccine trials, focusing on placebo-controlled trials in low- and middle-income countries.
Original language | English (US) |
---|---|
Pages (from-to) | 2126-2130 |
Number of pages | 5 |
Journal | Clinical Infectious Diseases |
Volume | 73 |
Issue number | 11 |
DOIs | |
State | Published - Dec 1 2021 |
Externally published | Yes |
Keywords
- Clinical trials data monitoring committees
- COVID-19 vaccines
- Ethics
- Research
- SARS-CoV-2
- Standard of care
ASJC Scopus subject areas
- Microbiology (medical)
- Infectious Diseases